🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Day one already well under way! #AATS2024

Sparks flying during a colorful debate on DPP vs NRP for DCD heart transplantation #AATS2024 Duke Surgery

Looking forward to a fantastic #ASGCT2024 and to presenting our late-breaking abstract on gene therapy for heart transplantation

Fascinating phase 1 trial for a novel AB-1002 gene therapy for advanced heart failure. Was well-tolerated with and demonstrated possible positive efficacy outcomes in patients with non-ischemic HF. Looking forward to the results of the ongoing phase 2 trial #asgct2024

Thank you to asaiojournal for the opportunity to present our work and for the award!

Congrats to Dr. Volk for a great presentation on Veterans at this year’s ASAIO!

Presenting our work on LVAD outflow graft obstruction as well as gene therapy for heart transplantation at the asaiojournal 70th Annual Conference. Honored to receive the top cardiac abstract and top overall abstract awards on behalf of Duke Surgery and DukeCTSurgery! 🏆

Survival after partial heart transplantation in a piglet model | Scientific Reports nature.com/articles/s4159…

Surgical Protocol for Partial Heart Transplantation in Growing Piglets - ⁦Joseph W Turek⁩ ⁦Cathlyn Medina⁩ ⁦Mary Moya-Mendez⁩ ⁦Sydney Jeffs⁩ ⁦Lillian⁩ journals.sagepub.com/doi/10.1177/21…

Congratulations to Dr. Allan Kirk on receiving the prestigious Lifetime Achievement Award from American Society of Transplantation (AST)! 👏

Congratulations to Dr. Jeffrey Keenan, Assistant Professor of Surgery DukeCTSurgery, for being named to the editorial board of Annals of Surgery! bit.ly/3yYf2R2

In patients undergoing post-MI VSR re-repair, our experience Cleveland Clinic Heart, Vascular & Thoracic suggests modern advances are associated w/ improved outcomes—operative mortality 56% pre-2001 vs. 10% after. Referral to expert centers should be considered for complex cases. jtcvstechniques.org/article/S2666-…

news.emory.edu/stories/2024/1…

One of our Rutgers RWJMS Surgery coresidents, Krish Dewan, MD, presenting his recent work finding a novel diagnostic approach to antibody-mediated rejection in #hearttransplant with DukeCTSurgery at the podium at The ISHLT. Nice job, Krish. #ishlt2025

Biopsy-negative rejection is frequent, and better tools are needed to diagnose and predict AMR. Dr. Krish Dewan Krish Dewan, MD proposes combining H&E, Pu.1+CD31 double stain, and cfDNA. 📌 Triple-positive patients had worse hemodynamics, ⬆️ rejection, and ⬆️ mortality. #ISHLT2025

Thank you AATS for the honor of presenting our work. Gene therapy to prevent rejection after heart transplantation is well on its way in the road from bench to bedside #AATS2025 DukeCTSurgery Duke Surgery Rutgers RWJMS Surgery

Congratulations Krish Dewan, MD !! Not surprising at all, always an absolute rockstar!! Well deserved! #AATS2025

Unbelievably grateful for this honor - it speaks more to the mentorship DukeCTSurgery more than anything else #AATS2025 Rutgers RWJMS Surgery

Congratulations Dr Joseph Coselli, MD 2025 AATS Lifetime Achievement Award recipient. Dr Coselli is a surgeon scientist, servant leader, mentor, and gentleman. #AATS2025 #Inspiration #AortaEd

Krish Dewan, MD, Post-Doctoral Research Fellow, has been awarded the C. Walton Lillehei Award for Basic Science at the 2025 Thoracic Surgery Annual Meeting. Congratulations on this achievement, Dr. Dewan! Read more: duke.is/6/kz8z